JPRN-jRCT2080221749未知2 期
A Phase 2 Study of RTA 402 in CKD Patients With Type 2 Diabetes Mellitus
Kyowa Hakko Kirin Co., Ltd.0 个研究点目标入组 40 人开始时间: 2012年3月28日最近更新:
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •CKD patients with type 2 diabetes mellitus
- •-Patients whose eGFR levels are eligible for this study
- •-Patients being treated with stable dose of ACE inhibitors and/or ARB etc.
排除标准
- •-Patients with Type 1 diabetes
- •-Patients with known non-diabetic renal disease
- •-Patients with a history of renal transplantation
- •-Patients with mean SBP > 160 mmHg or mean DBP > 90 mmHg
- •-Patients with HbA1C > 10%
- •-Patients with cardiovascular disease specified in the study protocol etc.
研究者
相似试验
未知
2 期
A Phase 2 GFR Measuring Study of RTA 402 in CKD Patients With Type 2 Diabetes MellitusJPRN-jRCT2080221750Kyowa Hakko Kirin Co., Ltd.20
终止
2 期
A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes MellitusType 2 DiabetesChronic Kidney DiseaseNCT01574365Kyowa Kirin Co., Ltd.53
终止
2 期
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes MellitusType 2 DiabetesChronic Kidney DiseaseNCT01572610Kyowa Kirin Co., Ltd.11
已完成
2 期
The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI StudyType 2 DiabetesChronic Kidney DiseaseNCT02316821Kyowa Kirin Co., Ltd.216
未知
2 期
Phase II clinical study of TY-0201 in patients with chronic heart failureChronic heart failureJPRN-jRCT2080222593TOA EIYO LTD.40